Vis enkel innførsel

dc.contributor.authorPejovic, Nicolas
dc.contributor.authorHöök, Susanna Myrnerts
dc.contributor.authorByamugisha, Josaphat
dc.contributor.authorAlfvén, Tobias
dc.contributor.authorLubulwa, Clare
dc.contributor.authorCavallin, Francesco
dc.contributor.authorNankunda, Jolly
dc.contributor.authorErsdal, Hege Langli
dc.contributor.authorBlennow, Mats
dc.contributor.authorTrevisanuto, Daniele
dc.contributor.authorTylleskär, Thorkild
dc.date.accessioned2021-04-30T08:28:10Z
dc.date.available2021-04-30T08:28:10Z
dc.date.created2020-12-14T19:26:04Z
dc.date.issued2020
dc.PublishedNew England Journal of Medicine. 2020, 383 (22), 2138-2147.
dc.identifier.issn0028-4793
dc.identifier.urihttps://hdl.handle.net/11250/2740498
dc.description.abstractBackground: Face-mask ventilation is the most common resuscitation method for birth asphyxia. Ventilation with a cuffless laryngeal mask airway (LMA) has potential advantages over face-mask ventilation during neonatal resuscitation in low-income countries, but whether the use of an LMA reduces mortality and morbidity among neonates with asphyxia is unknown. Methods: In this phase 3, open-label, superiority trial in Uganda, we randomly assigned neonates who required positive-pressure ventilation to be treated by a midwife with an LMA or with face-mask ventilation. All the neonates had an estimated gestational age of at least 34 weeks, an estimated birth weight of at least 2000 g, or both. The primary outcome was a composite of death within 7 days or admission to the neonatal intensive care unit (NICU) with moderate-to-severe hypoxic–ischemic encephalopathy at day 1 to 5 during hospitalization. Results: Complete follow-up data were available for 99.2% of the neonates. A primary outcome event occurred in 154 of 563 neonates (27.4%) in the LMA group and 144 of 591 (24.4%) in the face-mask group (adjusted relative risk, 1.16; 95% confidence interval [CI], 0.90 to 1.51; P=0.26). Death within 7 days occurred in 21.7% of the neonates in the LMA group and 18.4% of those in the face-mask group (adjusted relative risk, 1.21; 95% CI, 0.90 to 1.63), and admission to the NICU with moderate-to-severe hypoxic–ischemic encephalopathy at day 1 to 5 during hospitalization occurred in 11.2% and 10.1%, respectively (adjusted relative risk, 1.27; 95% CI, 0.84 to 1.93). Findings were materially unchanged in a sensitivity analysis in which neonates with missing data were counted as having had a primary outcome event in the LMA group and as not having had such an event in the face-mask group. The frequency of predefined intervention-related adverse events was similar in the two groups. Conclusions: In neonates with asphyxia, the LMA was safe in the hands of midwives but was not superior to face-mask ventilation with respect to early neonatal death and moderate-to-severe hypoxic–ischemic encephalopathy.en_US
dc.language.isoengen_US
dc.publisherMassachusetts Medical Societyen_US
dc.titleA randomized trial of laryngeal mask airway in neonatal resuscitationen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright © 2020 Massachusetts Medical Society. All rights reserved.en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1056/NEJMoa2005333
dc.identifier.cristin1859723
dc.source.journalNew England Journal of Medicineen_US
dc.source.40383
dc.source.1422
dc.source.pagenumber2138-2147en_US
dc.relation.projectNorges forskningsråd: 250531en_US
dc.identifier.citationNew England Journal of Medicine. 2020, 383, 2138-2147.en_US
dc.source.volume383en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel